ArticlePloS one2025
Layer-specific proteomic analysis of human hearts in patients with sudden cardiac death.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRecent studies have shown that decreased longitudinal strain in speckle-tracking echography can predict sudden cardiac death (SCD) in patients with cardiac hypertrophy (CH). Histologically, the heart wall consists of the inner longitudinal, middle circular, and outer longitudinal layers. Thus, layer-specific proteomic changes may contribute to SCD risk.
methodsThe three layers in human cardiac tissues were obtained during autopsies of SCD, compensated CH, and control cases (18 cases aged > 40 years, 54 samples in total). SCD cases consisted of patients with ischemic or hypertensive heart failure, whereas CH and control cases were accidental deaths. After histological analysis, cardiomyocytes were collected separately from the three layers of the left ventricular wall using laser microdissection. The extracted proteins were analyzed using liquid chromatography-tandem mass spectrometry, followed by label-free quantification. RESULTS AND DISCUSSION: Histologically, cardiomyocytes were enlarged in all layers of SCD and CH cases without significant progression of myocardial fibrosis. The proteomic profiles of SCD and CH cases were distinguishable from those of control cases, especially in the inner layer. The levels of mitochondrial and calcium-handling proteins were significantly decreased in SCD hearts. Arrhythmogenic changes, including decreased PKP2 and RYR2 levels, developed in a stepwise manner from control through CH to SCD, most prominently in the inner layer. Immunohistochemical analysis showed reduced levels of PKP2 in intercalated disks and RYR2 in sarcomeres. Because proteomic alterations precede the progression of myocardial fibrosis, their detection may enhance the accuracy of postmortem diagnosis of SCD in middle-aged and older asymptomatic individuals with CH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.